PCA
VRTX icon

Personal Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Personal Capital Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$218K Sell
756
-102
-12% -$31.1K ﹤0.01% 450
2022
Q3 		$248K Sell
858
-50
-6% -$14.4K ﹤0.01% 398
2022
Q2 		$256K Buy
908
+77
+9% +$20.6K ﹤0.01% 379
2022
Q1 		$217K Sell
831
-312
-27% -$74K ﹤0.01% 467
2021
Q4 		$251K Buy
1,143
+3
+0.3% +$583 ﹤0.01% 473
2021
Q3 		$207K Buy
+1,140
New +$223K ﹤0.01% 478

Other funds holding VRTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return